U.S. Luxury Stock News

NYSE:SEM
NYSE:SEMHealthcare

Is It Time To Reassess Select Medical Holdings (SEM) After Recent 2026 Guidance Update?

If you are wondering whether Select Medical Holdings at US$16.45 is still reasonably priced or already stretched, the valuation story is where things start to get interesting. The stock has been relatively steady in the short term, with returns of 0.1% over the last week and 0.5% over the last month, while the 11.0% year to date and 11.1% one year returns sit alongside a 16.0% three year return and a decline of 11.6% over five years. Recent coverage has focused less on short term headlines...
NasdaqGS:ECHO
NasdaqGS:ECHOMedia

EchoStar (SATS) Q1 Loss Shrink Challenges Bearish Narratives On Deep Trailing Losses

EchoStar’s latest numbers set the stage for a changing profitability story EchoStar (SATS) opened 2026 with Q1 revenue of US$3.7b and a basic EPS loss of US$0.51, alongside a trailing twelve month EPS loss of US$50.11 that highlights how deep the recent earnings pressure has been. Over the past five quarters, revenue has moved between US$3.6b and US$4.0b while quarterly basic EPS has swung from a profit of US$1.19 in Q4 2024 to losses of US$0.51 to US$44.37 through 2025, setting a wide...